JMP Securities Reaffirms Their Buy Rating on Blueprint Medicines (BPMC)
JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
JMP Securities Reaffirms Their Buy Rating on Kemper (KMPR)
JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...
JMP maintains Apollo stock Market Perform rating
JMP Securities maintained its Market Perform rating on Apollo Global Management (NYSE:APO) shares without setting a new price ...
JMP Securities holds Capital Southwest stock at Market Perform
JMP Securities maintained a Market Perform rating on Capital Southwest Corporation (NASDAQ:CSWC), reflecting a consistent performance and solid fundamentals. The firm's analyst highlighted CSWC's ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
Meta's AI Investments, Llama Expansion, Ad Tech Growth Earn Analyst Conviction
Meta Platforms, Inc (NASDAQ:META) stock is trading higher after multiple firms raised their price forecasts on the stock ...